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Porcine reproductive and respiratory syndrome virus (PRRSV) is an important swine pathogen. Here we
applied the DNA shufﬂing approaches to molecularly breed the PRRSV GP3 gene, a neutralizing
antibodies inducer, in an attempt to improve its heterologous cross-neutralizing ability. The GP3 genes
of six different PRRSV strains were bred by traditional DNA shufﬂing. Additionally, synthetic DNA
shufﬂing of the GP3 gene was also performed using degenerate oligonucleotides. The shufﬂed-GP3-
libraries were cloned into the backbone of a DNA-launched PRRSV infectious clone pIR-VR2385-CA.
Four traditional-shufﬂed chimeras each representing all 6 parental strains and four other synthetic-
shufﬂed chimeras were successfully rescued. These chimeras displayed similar levels of replication
both in vitro and in vivo, compared to the backbone parental virus, indicating that the GP3 shufﬂing did
not impair the replication capability of the chimeras. One chimera GP3TS22 induced signiﬁcantly
higher levels of cross-neutralizing antibodies in pigs against a heterologous PRRSV strain FL-12.
& 2012 Elsevier Inc. All rights reserved.Introduction
Porcine reproductive and respiratory syndrome (PRRS), arguably
the most economically-important global swine disease for the pork
industry today (Garner et al., 2001; Lunney et al., 2010; Neumann
et al., 2005; Pejsak et al., 1997), is characterized by reproductive
failure in sows and respiratory disease in piglets (Wensvoort et al.,
1992). The emergence of PRRS was ﬁrst recognized in the United
States in 1987 (Keffaber, 1989) and it subsequently became
panzootic worldwide (Albina, 1997; Botner et al., 1994; Hopper
et al., 1992; Kuwahara et al., 1994). The disease has devastated the
global swine industry, and the economic losses associated with PRRS
are approximately $560.32 million per year in the United States
alone (Neumann et al., 2005). In 2006, outbreaks of an unparalleled
large-scale, highly pathogenic PRRS (known as swine high fever
disease) occurred in China and its neighboring countries with 20–
100% mortality, which resulted in a dramatic decline of pork
supplies and bankruptcy of large numbers of pig farms in China
(Tian et al., 2007; Zhou et al., 2009b).ll rights reserved.
ical Sciences and Pathobiol-
981 Kraft Drive, Blacksburg,The causative agent of PRRS, porcine reproductive and respiratory
syndrome virus (PRRSV), is classiﬁed in the family Arteriviridae of the
order Nidovirales (Cavanagh, 1997). There are two major types of
PRRSV: type 1 (the European type) and type 2 (the North American
type) with only approximately 55–70% nucleotide sequence identity
between these 2 types (Benﬁeld et al., 1992; Nelsen et al., 1999;
Ropp et al., 2004; Wensvoort et al., 1991). PRRSV is heterogenic with
extensive genetic and antigenic variations among ﬁeld strains (Meng,
2000; Nelsen et al., 1999). Within the type 1 European PRRSV, there
exist at least 3 distinct genetic lineages (Forsberg et al., 2002), and
similarly, at least 9 distinct genetic lineages were identiﬁed within
the North American type 2 PRRSV (Shi et al., 2010). The observed
extensive genetic variations among ﬁeld strains of PRRSV are largely
responsible for the lack of efﬁcient cross-protection of the current
modiﬁed live-attenuated vaccines (MLVs) against heterologous ﬁeld
strains (Zuckermann et al., 2007). The current commercial MLVs,
which are all based on a single strain of PRRSV, are effective in
protection against homologous or genetically similar strains but are
generally ineffective against heterologous ﬁeld strains (Dwivedi et al.,
2011; Meng, 2000). The majority of ﬁeld strains of PRRSV circulating
in swine herds today are genetically different from the MLVs,
therefore development of future vaccines must take into considera-
tion the heterogenetic nature of PRRSV or PRRS will remain difﬁcult
to control.
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which contains a 5-capped and 3-polyadenylated genome of
approximately 15 kb (Conzelmann et al., 1993; Meulenberg
et al., 1993; Snijder and Meulenberg, 1998). The viral genomic
RNA contains at least nine open reading frames (ORFs). ORF1a and
ORF1b encode the replicase polyprotein that is responsible for
viral replication and transcription. ORFs2–4 encode virion-
associated proteins GP2, GP2b, GP3, and GP4, respectively
(Meulenberg and Petersen-den Besten, 1996; van Nieuwstadt
et al., 1996; Wu et al., 2001). The ORFs5–7 encode the major
envelope (GP5), membrane (M), and nucleocapsid (N) proteins,
respectively (Mardassi et al., 1995; Meulenberg et al., 1995). A
small ORF5a protein was recently found to play a role in PRRSV
infection (Firth et al., 2011; Johnson et al., 2011; Tian et al., 2012).
PRRSV expresses its structural proteins ORFs2–7 from a nested set
of subgenomic mRNA by using a discontinuous transcription
mechanism (Lunney et al., 2010; Meng et al., 1996b).
The GP3 encoded by the ORF3 is a minor structural protein of
PRRSV and contains 254 amino acids (aa) with a molecular mass of
approximately 42 kDa (de Lima et al., 2009; Jiang et al., 2007). The
GP3 interacted with GP2 and GP4 to form a multi-protein complex
that is dispensable for virion formation but important for viral
infectivity (Das et al., 2011; de Lima et al., 2009; Wissink et al.,
2005). The GP3 consists of a 30 aa signal peptide at its N-terminus
that is cleaved from its mature protein (Zhou et al., 2006). It has
been shown that antibodies against GP3 play an important role in
viral clearance (Plana Duran et al., 1997), and that the GP3 induces
protective immunity against PRRSV (Cancel-Tirado et al., 2004;
Jiang et al., 2007; Jiang et al., 2008; Kim and Yoon, 2008). At least
7 antigenic epitopes have been identiﬁed in the GP3 protein
(de Lima et al., 2006; Vanhee et al., 2011; Zhou et al., 2006), although
the location of the neutralizing epitope(s) remains unknown. It has
recently been demonstrated that an N-glycan moiety located in GP3
is responsible for glycan shield interference, which can inﬂuence the
ability to produce neutralizing antibodies (Vu et al., 2011). The GP3 is
one of the most variable structure proteins of PRRSV with 86–98% aa
sequence identity among type 2 PRRSV strains (Kapur et al., 1996;
Mardassi et al., 1995; Meng et al., 1995; Morozov et al., 1995), and
only 54–60% identity between type 1 and type 2 strains (Mardassi
et al., 1995; Murtaugh et al., 1995).
DNA shufﬂing mimics the natural recombination process at a
much accelerated rate and has been used for directing the
evolution of genes (Apt et al., 2006; Callison et al., 2005; Li
et al., 2008; Locher et al., 2005; Pekrun et al., 2002; Soong et al.,
2000; Yang et al., 2009). By using DNA shufﬂing, the recombi-
nants with new patterns of phenotypes can be rapidly screened
and identiﬁed (Soong et al., 2000). Two types of DNA shufﬂing
currently exist, traditional shufﬂing and synthetic shufﬂing, to
generate the shufﬂed DNA libraries. In the traditional DNA
shufﬂing, the target genes from selected parental viral strains
are digested with DNase I to produce a pool of short DNA
fragments, which are then reassembled by PCR. In the synthetic
DNA shufﬂing, degenerate oligonucleotides based on known
sequences are synthesized and used to directly assemble into a
shufﬂed DNA library of target genes by PCR. The shufﬂed chimeric
viruses can be screened for desired properties such as improved
cross-neutralizing ability to heterologous virus strains(Apt et al.,
2006). Therefore, DNA shufﬂing offers a unique and powerful
approach to improve antigenic cross-reactivity.
In this study we breed PRRSV by the traditional DNA shufﬂing
of GP3 genes of 6 different PRRSV strains and by the synthetic DNA
shufﬂing of the available GP3 genes in GenBank database. The
resulting shufﬂed chimeric viruses were infectious in vitro, and the
antisera from pigs experimentally infected with one of the shufﬂed
chimeric viruses acquired an improved cross-neutralizing ability
in vitro against a heterologous PRRSV strain.Results
Generation of infectious chimeric viruses containing shufﬂed GP3
genes from 6 different PRRSV strains by traditional DNA shufﬂing
To minimize potential lethal mutations of the resulting
chimeric viruses, the signal peptide sequence, transcription reg-
ulatory sequence (TRS) and the downstream GP3–GP4 overlap-
ping region were excluded in the DNA shufﬂing, and thus the
shufﬂed GP3 region includes only nt 151–515 (365 bp) of the GP3
gene. The individual GP3 gene fragment from each of the six
different PRRSV strains (VR2385, VR2430, MN184B, JXA1, FL-12
and NADC20) (Shi et al., 2010) (Fig. 1A) was used for the
traditional DNA shufﬂing with DNase I digestion and followed
by PCR reassembly without primer. A PCR product with the
expected size was ampliﬁed by PCR with speciﬁc PCR primers
ﬂanking the shufﬂed region using the reassembly products as the
template. To accelerate the shufﬂing process, a new round of
traditional DNA shufﬂing process was iterated by using the
shufﬂed DNA pool as the parents to produce a well-shufﬂed
library of the GP3 genes (Chang et al., 1999; Zhang et al., 1997).
To clone the shufﬂed GP3 fragments into the DNA-launched
PRRSV VR2385 infectious clone, two ﬂanking fragments (1926 bp
and 524 bp, respectively) ampliﬁed from the infectious clone
backbone were linked to the shufﬂed GP3 fragment by a fusion
PCR. The unique restrict enzyme sites, Bsr GI and Acl I, in the
ﬂanking fragments were used to clone the fusion product into the
VR2385 backbone to produce the GP3 shufﬂed library. The
shufﬂed GP3 region from 36 randomly selected individual clones
was each sequenced and compared with the corresponding
sequences of the six parental strains. Based on sequence analyses,
four chimeric clones designated as GP3TS1, GP3TS6, GP3TS20 and
GP3TS22 (traditional shufﬂing, TS) from the 36 selected clones
were found to be well-shufﬂed and contain regions from all six
parental virus strains (Fig. 1B and Fig. 2). The GP3 nucleotide
sequences of the chimeric viruses were compared to those of the
parental viruses, and the differences were presented in Fig. 2.
Subsequently, four viable chimeric viruses were successfully
rescued from MARC-145 cells that were infected with the super-
natant of BHK-21 cells transfected with DNA-launched infectious
clone containing the shufﬂed GP3 fragments (Fig. 3).
Generation of infectious chimeric viruses by synthetic DNA shufﬂing
of the GP3 genes
Degenerate oligonucleotide primers based on the available
GP3 gene sequences of PRRSV were designed and used for the
synthetic DNA shufﬂing (Fig. 4). The library of the DNA-launched
VR2385 infectious clone containing synthetic shufﬂed GP3 genes
was transfected into BHK-21 cells. IFA with PRRSV-speciﬁc
monoclonal antibody was performed to conﬁrm that infectious
chimeric viruses were successfully rescued from the MARC-145
cells infected with the supernatant of transfected BHK-21 cells
(Fig. 3). After plaque puriﬁcation, the GP3 gene sequences from 17
individual chimeric clones were determined. By comparing the
sequences of the 17 chimeras along with the backbone parental
strain VR2385 in a multiple sequence alignment, we selected four
viable chimeric viruses representing the best diversity for further
study, designated as GP3SS5, GP3SS10, GP3SS17 and GP3SS22
(synthetic shufﬂing, SS), respectively (Fig. 2).
The shufﬂed chimeric viruses had similar levels of replication with the
parental VR2385 virus
We used the VR2385 virus as the parental virus backbone to
determine if a VR2385 chimera with a shufﬂed GP3 can acquire an
Fig. 1. Infectious chimeric viruses generated by traditional DNA shufﬂing and their parental viruses: (A): A phylogenetic tree based on the GP3 nucleotide sequences of
selected type 2 North American PRRSV strains. The 6 parental viruses (VR2385 JX044140, VR2430 JX050225, MN184B DQ176020, FL-12 AY545985, JXA1 EF112445 and
NADC20 JX069953) are indicated with boldface in the tree. The phylogenetic tree was constructed using the neighbor-joining method with bootstraps in 100 replicates.
The numbers above each branch indicate the bootstrap values (percentage of consensus support in bootstrap). (B): A schematic diagram of the chimeric GP3 nucleotide
sequences in four representative chimeras (GP3TS1, GP3TS6, GP3TS20 and GP3TS22) generated by traditional DNA shufﬂing. Each pattern in the shufﬂed GP3 gene
represents the one of the six different individual parental virus strains, which were shown at the bottom. The crossovers were delineated by the diversity of nucleotides
because of the incorporation of different parental virus strains. Multiple patterns that were displayed at the same region of the shufﬂed GP3 gene indicated that the
sequence in this particular region was conserved at the corresponding parental virus strains.
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Fig. 2. Nucleotide sequence alignment of the shufﬂed GP3 region of chimeric viruses and their parents: A multiple sequence alignment of nucleotide sequences in the
shufﬂed GP3 region (151–515 nt) was performed by clustalW method for the eight chimeric viruses and six parental viruses. The sequence of the parental backbone virus
VR2385 was shown on top, and only differences were indicated for other viruses.
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focused only on comparing the growth characteristics of the 8
GP3-shufﬂed chimeric viruses with the backbone parental virus
VR2385, but not with the other 5 GP3 parental viruses, to
determine if GP3 shufﬂing has any effect on the replication ability
of these chimeric viruses on MARC-145 cells. The growth kineticsof the nine viruses were analyzed in MARC-145 cells. The results
showed that there was no signiﬁcant difference in the replication
level between the chimeric viruses and the backbone parental
virus VR2385 at any time point (Fig. 5), suggesting that the GP3
shufﬂing did not impair the replication ability of these eight
chimeric viruses.
Fig. 4. Schematic diagram of synthetic DNA shufﬂing of the PRRSV GP3 genes: A total of 9 backbone degenerate oligonucleotides (g3F1–g3F4, g3R1–g3R5), shown as arrows,
were designed to cover the entire shufﬂing region from nt position 151 to 515 in the GP3 gene. The sequences in the overlap regions between backbone oligonucleotides were
conserved with the sequence of the infectious clone backbone VR2385 virus, and the diversity of the overlap regions was induced by spike primers (S1–S12).
Fig. 3. Rescue of infectious chimeric viruses from four individual traditional shufﬂed infectious clones or from synthetic shufﬂed library: Immunoﬂuorescence assay (IFA)
with anti-PRRSV N protein monoclonal antibody (SDOW17) was used to conﬁrm that the chimeric viruses were successfully rescued in MARC-145 cells infected with the
supernatant of BHK-21 cells transfected with four individual clones generated by traditional DNA shufﬂing (GP3TS1, GP3TS6, GP3TS20, and GP3TS22) or with synthetic
shufﬂed library (GP3SSlibrary). Parental backbone strain VR2385 and mock infection were included as positive and negative controls, respectively.
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to that of the parental virus VR2385 in pigs
Three pigs from each group were inoculated with each of the
8 chimeric viruses (test groups), parental virus VR2385 (positive
control group) or culture media (negative control group). One pig
in the GP3TS6 group died of a perforated gastric ulcer at 2 days
post-inoculation (DPI). The infectious titers of chimeric viruses
(except for chimera GP3SS22) in serum samples of the infected
pigs at 7 DPI were similar to that of the VR2385 with no
signiﬁcant difference. The average serum infectious titer of
chimera GP3SS22 was signiﬁcantly lower (p¼0.049) than that
of the VR2385 at 7 DPI in the infected pigs (Fig. 6A). However,
there was no signiﬁcant difference in the serum viral infectioustiters between all the other chimeric virus groups and positive
control group at 14 DPI (Fig. 6B). The viremia in groups GP3TS 6,
GP3TS22, GP3SS17, GP3SS22 and VR2385 was cleared at 21 DPI
and the viremia in the remaining groups was cleared at 28 DPI.
The majority of the chimeric viruses elicited similar levels of anti-
PRRSV antibody responses compared to the wild-type VR2385 virus
in pigs
The anti-PRRSV antibody responses in serum samples were
tested by using the IDEXX HerdCheck X3s ELISA and displayed as
S/P ratio. The results showed that all groups of pigs seroconverted
at 14 DPI, and remained seropositive for the duration for the
study at a relatively stable level. Seven of the 8 chimeric viruses
Fig. 6. Infectious virus titers in serum samples of the pigs infected with eight
chimeric viruses or with the backbone parental virus VR2385 at 7 and 14 days
post-inoculation (DPI): (A): Infectious PRRSV titers in serum samples collected at
7 DPI from pigs infected with chimeric viruses, backbone parental virus VR2385 or
inoculated with cells culture media, respectively. (B): The infectious viral titers in
serum samples at 14 DPI from pigs infected with chimeric viruses, VR2385 or cell
culture media, respectively. The asterisk (*) sign indicates a signiﬁcant difference
between the chimeric virus and parental strain VR2385.
Fig. 7. Anti-PRRSV antibody responses from pigs infected with eight chimeric
viruses or with the parental virus VR2385: The IDEXX HerdCheck X3s ELISA for
PRRS was used to detect anti-PRRSV antibodies in pigs infected with chimeric
viruses, VR2385 and control. The levels of antibody were expressed as a sample
value/positive value (S/P) ratio. A ratio of 0.4 was considered as positive.
The asterisk (*) signs indicate a signiﬁcant difference between the chimera
GP3TS22 and the parental strain VR2385.
Fig. 5. In vitro growth kinetics of the chimeric viruses: The growth kinetics of
chimeric viruses in MARC-145 cells was determined by measuring the infectious
viral titers (TCID50/ml) at indicated time points post-infection using the micro-
titration infectivity assay. The experiments were done in triplicate.
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(Fig. 7). However, when compared to the antibody titer (S/P ratio)
of the wild-type VR2385, the chimera GP3TS22 group displayed a
lower antibody titer in all time points with signiﬁcant differences
at 14, 28, 35 and 42 DPI. The pigs in the negative control group
were seronegative for PRRSV throughout the study (Fig. 7).A chimeric virus with shufﬂed GP3 genes displayed an improved
cross-neutralizing ability against a heterologous PRRSV strain
To investigate if the shufﬂing of GP3 genes from 6 different
strains can confer the chimeric viruses with an improved cross-
neutralizing ability against heterologous virus strains, the anti-
PRRSV neutralizing antibody (NA) titers in serum samples col-
lected at 42 DPI were determined by a cross-neutralization serum
virus neutralization (SVN) assay with each of the ﬁve available
parental virus strains (VR2385, VR2430, MN184B, FL-12 and
NADC20), respectively. The NA titers were expressed as highest
times (‘‘n’’) of 2-fold serial dilution (2n or the power of 2) of the
serum sample that showed a 90% or greater reduction in the
number of positive ﬂuorescent foci. In the SVN test against the
homologous strain VR2385, the NA titer in sera of the positive
control group reached 4 (1:16), and the NA titers for the chimeric
virus groups were between 3 (1:8) and 4 (1:16) (Fig. 8A), which
was not signiﬁcantly different, suggesting that the shufﬂed GP3
genes did not impair the cross-neutralizing ability of the chimeric
viruses against the backbone parental PRRSV strain. In the SVN
test against strain VR2430, which belongs to the same lineage but
a different sublineage with VR2385 in the phylogenetic tree (51),
the NA titers of chimeras GP3TS20 and GP3TS22 reached to 3.78
(1:14), slightly higher than that of the VR2385, which were 3.11
(1:9). The NA titers of chimeras GP3TS6 and GP3SS22 were
slightly lower than that of VR2385 group, and the NA titers for
the remaining chimeric virus groups were similar to that of
VR2385 (Fig. 8B). However, there was no signiﬁcant difference
in the NA titers between the chimeric viruses and the VR2385 to
cross-neutralize the VR2430 virus (Fig. 8B).
In the SVN test against heterologous strain MN184B, the NA
titers from all chimeric virus groups were low (o2 or 1:4) or even
undetectable (Fig. 8C). The results from the SVN test against
heterologous strain FL-12 revealed that the NA titers of the
chimera GP3TS22-infected group were signiﬁcantly higher than
that of the VR2385 group (p¼0.041). Similar to chimera GP3TS22,
the NA titers of the chimera GP3TS1 group were also higher than
that of the VR2385 although there was no signiﬁcant difference
(Fig. 8D). In the SVN test for heterologous strain NADC20, similar
to what was observed for the FL-12 strain, the NA titers of the
chimera GP3TS22 were also higher than that of the VR2385,
although the difference was not signiﬁcant (p¼0.076). The NA
titers of the other chimeric virus groups were similar to that of
the VR2385 (Fig. 8E). To further analyze the cross-neutralizing
Fig. 8. Neutralizing antibody titers against homologous and heterologous parental strains in serum samples from pigs infected with eight chimeric viruses or with the
parental virus VR2385, respectively: (A–E): Neutralizing antibody (NA) titers in serum samples collected at 42 DPI from pigs infected with chimeric viruses or VR2385.
In vitro cross-neutralization SVN test of respective serum samples was performed against the ﬁve available parental virus strains used in the shufﬂing including VR2385,
VR2430, MN184B, FL-12 and NADC20, respectively. F: Composite NA titers against all 4 heterologous strains (VR2430, MN184, FL-12 and NADC20). The NA titers against
the heterologous strains in pigs infected with chimeric strains were averaged and summarized individually, and compared with that in pigs infected with VR2385. The NA
titers were calculated as the highest 2-fold dilution (2n) of the serum sample that showed a 90% or greater reduction in the number of positive ﬂuorescent foci, compared
to that of the serum samples from the negative control group in the same dilution. Three independent experiments were performed for each test, and the average NA titer
for each group of pigs (3 pigs) was shown in the ﬁgure. The error bars indicated standard errors. The asterisk (*) signs indicate a signiﬁcant difference between the group of
chimera GP3TS22 pigs and the backbone parental strain VR2385.
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four heterologous parental strains were composited, and com-
pared with that of VR2385 (Fig. 8F). The composite NA titer of the
chimera GP3TS22 was higher than that of wild-type VR2385 but
the difference was not signiﬁcant (p¼0.062). The neutralizing
antibodies in the serum samples of negative control group against
each parental virus strain were also tested but were undetectable.
The results from the cross-neutralizing SVN test indicated that
the shufﬂing of GP3 genes from different strains contributed to an
improved heterologous cross-neutralizing ability of one chimeric
virus (GP3TS22).
To further investigate the kinetics of neutralizing antibodies at
different time points of the infection process, serum samples
collected at 28, 35 and 42 DPI from pigs infected by two chimeric
viruses (GP3TS20 and GP3TS22) with higher cross-neutralizing
activities as well as the parental VR2385 virus were tested for the
NA titers against four homologous/heterologous parental strains
(VR2385, MN184B, FL-12, and NADC20). In the SVN test against
homologous VR2385, the NA titers in the three virus groups were
similar, with approximately 3 (1:8) at 28 DPI to 4 (1:16) at 42 DPI
(Fig. 9A). Once again, the NA titers against MN184B were very low
in all groups, and were mostly undetectable until 42 DPI (Fig. 9B).The results of SVN test against the heterologous FL-12 strain
showed that the NA titers in serum samples from chimeric virus
groups appeared earlier than that in the VR2385 group, and the
NA titer of chimera GP3TS22 group was signiﬁcantly higher than
that of the VR2385 at 42 DPI (p¼0.041) (Fig. 9C). The NA titers for
strain NADC20 were detected as early as at 28 DPI but the titers
were lower than 3 (1:8), even at 42 DPI (Fig. 9D).
The shufﬂed chimeric viruses were stable in pigs
The GP3 genes of the chimeric viruses recovered from infected
pigs at 14 DPI were ampliﬁed by RT-PCR, and sequenced.
Sequence analyses revealed that the GP3 gene region sequences
of the eight chimeric viruses recovered from pigs at 14 DPI are the
same as the original virus inocula, suggesting that the chimeric
viruses are genetically stable in pigs.
Epitopes analysis indicated that GP3 shufﬂing might induce epitopes
change in the chimeric viruses
To determine if the GP3 shufﬂing introduced mutations in the
antigenic epitopes and to explore a potential correlation between
Fig. 9. Kinetics of neutralizing antibodies in serum samples collected at 28, 35 and 42 days post-inoculation (DPI) from pigs infected with chimeric viruses GP3TS20 and
GP3TS22 or with the backbone virus VR2385, respectively: The NA titers in serum sample at 28, 35 and 42 DPI from pigs infected with chimeras GP3TS20 and GP3TS22 or
with VR2385 were examined by an in vitro serum virus neutralization test against four parental virus strains VR2385, MN184B, FL-12 and NADC20, respectively. Each test
was performed in triplicate, the average NA titer of 3 pigs in each group was shown in the ﬁgure and the bars indicated standard errors. The asterisk (*) signs indicate a
signiﬁcant difference between the chimeric virus and the parental strain VR2385.
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analyzed both the nucleotide and amino acid sequences of the
GP3 of the chimeric viruses and six parental viruses (Figs. 2, 10).
Six of the seven known GP3 antigenic epitopes were located in the
shufﬂed region, and the 7th epitope that was not in the shufﬂed
region was completely conserved in all the six parental strains.
Sequence analyses showed that the GP3 shufﬂing produced at
least one or more epitope changes in all of the eight chimeric
viruses (Fig. 10), although many nucleotide changes are silent
with no change in the amino acid sequence. The DNA shufﬂing
not only imported the epitopes from parental virus strains into
chimeric viruses but also created potential new epitopes that
were different from the parental virus strains by recombination.
Compared to the parental backbone virus VR2385, the chimera
GP3TS22 with an improved cross-neutralizing activity against the
heterologous PRRSV strain FL-12 had two epitopes changed in
GP3 (EP-I, and EP-III) (Fig. 10). In addition, the chimera GP3TS22
shares the same EP-I epitope with chimera GP3TS1, which also
displayed an improved cross-neutralizing ability against hetero-
logous strain FL-12. The EP-I epitope from both chimera GP3TS1
and chimera GP3TS22 contains amino acid sequence of ‘QAA I E V
YEPGRS’, with two aa mutations (A64I, and A66V) compared to
the wild-type VR2385. The isoleucine residue at aa position 64
was imported from strain VR2430 but the valine residue at aa
position 66 does not belong to any of the parental virus strains. It
remains to be determined if this particular epitope in GP3 is a
neutralizing epitope that contributed to the improved cross-
neutralizing ability of the chimeric virus GP3TS22 against the
heterologous PRRSV strain FL-12.Discussion
Since its ﬁrst appearance in the United States in the late 1980s,
PRRS has been regarded as the most economically important
disease to the global swine industry (Garner et al., 2001;
Neumann et al., 2005; Pejsak et al., 1997). The recent outbreaks
of highly pathogenic PRRS (HP-PRRS) in China and other Asian
countries, caused by a variant strain of PRRSV, brought devastat-
ing economic losses in that region (Tian et al., 2007; Zhou et al.,
2009b). Since the ﬁrst outbreak of HP-PRRS in 2006, the variant
HP-PRRSV has now spread in Asia posing immense economic
concerns (Yu et al., 2012; Zhou et al., 2009a; Zhou and Yang,
2010).
The available PRRSV MLVs are still regarded as the best way to
protect pigs from PRRSV infection. The current commercial MLVs
are effective against homologous ﬁeld strains but the protections
against the heterologous strains are very limited (Christopher-
Hennings et al., 1997; Meng, 2000). Considering the extensive
genetic and antigenic variations among PRRSV strains and the fact
that most ﬁeld strains are genetically different from the MLV
vaccine strains (Opriessnig et al., 2002; Shi et al., 2010), it is
imperative that we explore new ways to develop a vaccine that
confer better heterologous protection.
Molecular breeding through DNA shufﬂing can direct the
evolution of viruses (Zhang et al., 1997), and is a powerful tool
to quickly obtain chimeric viruses with novel properties (Soong
et al., 2000). Thus far, DNA shufﬂing has been successfully used
for altering the viral tropism in cells (Yang et al., 2009), improving
virus stability and processing yields (Powell et al., 2000) or
Fig. 10. Analyses of the known GP3 antigenic epitopes in the shufﬂed GP3 region of chimeric viruses and their parents: Multiple sequence alignment of amino acid
sequences in the shufﬂed GP3 region of six parental virus strains and eight chimeric viruses was performed. The sequence of the backbone virus VR2385 was shown on top,
and only differences for other strains were indicated in the alignment. The arrows annotate the locations of the previously-identiﬁed epitopes in the shufﬂed GP3 region.
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(Apt et al., 2006). Unlike the sexual breeding, DNA shufﬂing can
breed the viral genomes from multiple parental virus strains at an
accelerated rate to broadly present the properties of different
parental virus strains in the shufﬂed chimeric viruses (Apt et al.,
2006; Locher et al., 2005). Therefore, DNA shufﬂing offers a
potential means to improve the heterologous cross-neutralizing
ability of PRRSV.
In this study, six parental PRRSV strains from different linage
or sublineage (Fig. 1A) were selected for DNA shufﬂing. Consider-
ing the low sequence identity of the GP3 genes between type
1 and type 2 PRRSV strains (Mardassi et al., 1995; Murtaugh et al.,
1995), which may cause problems in successfully rescuing viable
infectious chimeras, therefore in this study we only explored the
shufﬂing of the GP3 genes of type 2 PRRSV strains by both
traditional and synthetic DNA shufﬂing methods. The shufﬂed
chimeric viruses were rescued in MARC-145 cells. Eight well-
shufﬂed chimeric viruses were selected for further in vitro and
in vivo characterizations. We demonstrated that the levels of virus
replication in MARC-145 cells of the 8 chimeric viruses were
similar to that of the wild-type VR2385 virus, indicating that DNA
shufﬂing of the GP3 genes of PRRSV did not signiﬁcantly impair
the viability or the replication level of the chimeric viruses.
Similarly, the infection dynamics and replication levels for 7 of
the 8 chimeric viruses in pigs were similar to that of the parental
VR2385 virus as well, since the infectious virus titers in serum
samples of pigs infected by the chimeric viruses were similar to
that of the VR2385 virus-infected pigs, further indicating that the
GP3 shufﬂing did not signiﬁcantly impair the replication ability of
these chimeric viruses in vivo.
To investigate whether DNA shufﬂing of the GP3 gene can
generate chimeric viruses with an improved cross-neutralizing
ability against heterologous strains, pigs were infected with each
of the 8 chimeric viruses to produce neutralizing antibodies, and
subsequently their abilities to cross-neutralize 5 available homo-
logous/heterologous parental strains were evaluated in vitro by
the SVN test. The results showed that, like the backbone parental
virus VR2385, all 8 chimeric viruses still induce neutralizing
antibodies against the VR2385 strain as well as against agenetically-similar strain VR2430, which belongs to the same
genetic lineage with VR2385. This is expected, as the neutralizing
epitopes in GP3 region and other ORFs likely contributed to the
neutralization against VR2385 and VR2430. Among the 8 shufﬂed
chimeric viruses, most of them did not induce signiﬁcant cross-
neutralizing antibody titers against heterologous strains such as
MN184B, FL-12 and NADC20. However, one of the chimeric
viruses generated by traditional DNA shufﬂing, chimera GP3TS22,
induced signiﬁcantly higher titers of cross-neutralizing antibodies
against the heterologous FL-12 strain, and to a lesser extent (not
signiﬁcantly different), against heterologous strains MN184B and
NADC20 as well. Overall, the composite neutralizing antibody
titers of the chimera GP3TS22 were higher against the four
heterologous strains than that of wild-type VR2385, although
the difference was not signiﬁcant (Fig. 8F). The results demon-
strated that the GP3TS22 chimeric virus generated by DNA
shufﬂing of GP3 genes from multiple strains has an improved
cross-neutralizing ability against heterologous PRRSV strains.
Since the anti-PRRSV antibody level and the infectious virus
titers of chimeric viruses were generally similar to those of
VR2385 and since the homologous cross-neutralization between
the VR2385 and the chimeric viruses are also at a similar level, it
is likely that the chimeric viruses induce similar levels of immune
responses as the VR2385 did. Therefore, the observed difference
of the improved heterologous cross-neutralizing ability of the
chimeric virus GPSTS22 could be due to the changes of neutraliz-
ing epitopes in GP3 introduced by DNA shufﬂing. Sequence
analyses of the six previously-identiﬁed GP3 antigenic epitopes
in the shufﬂed region between chimeric viruses and the six
parental strains revealed that there exist changes in one or
multiple epitopes of all chimeric viruses that were introduced
by DNA shufﬂing. Some changes in the epitopes were imported
directly from the parental virus strains such as the EP-II and EP-III
of the chimera GP3TS20 that were imported from the parental
virus JXA1, while other changes in the epitopes were novel and
created by inner-epitope recombination through shufﬂing, such
as the EP-I of chimeras GP3TS1 and GP3TS22. Compared to the
known GP3 epitopes of the backbone wild-type VR2385 virus, the
chimera GP3TS22 with an improved cross-neutralizing ability
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III. Interestingly, the EP-I epitope change in the chimera GP3TS22
was the same as another chimera GP3TS1, which also displayed
an improved cross-neutralizing ability against the heterologous
FL-12 strain. Whether this EP-I epitope was the neutralizing
epitope that directly contribute to the improved cross-
neutralizing ability of chimeras GP3TS22 and GP3TS1 requires
further investigation. It is also possible that unknown novel
neutralizing epitope(s), in addition to the 7 known ones in the
GP3, may contribute to the improved cross-neutralizing ability of
the chimeric viruses.
In conclusion, by using both traditional and synthetic DNA
shufﬂing approaches, we successfully shufﬂed the GP3 genes of
multiple genetically distinct strains of PRRSV and rescued eight
infectious chimeric viruses with well-shufﬂed GP3 gene. The
shufﬂed chimeric viruses generally had similar levels of replica-
tion both in vitro and in vivo when compared to the backbone
parental VR2385 virus, indicating the GP3 shufﬂing did not
signiﬁcantly impair the replication ability of the chimeras.
Importantly, we identiﬁed one shufﬂed chimeric virus (GP3TS22)
with an improved cross-neutralizing ability against a heterolo-
gous virus strain FL-12. We also showed that the GP3 of PRRSV is
important for viral neutralization. It is well documented that
there is a good correlation between in vitro neutralizing activity
and in vivo protection (Burton, 2002), and that the neutralizing
antibody is an important correlate of protection against PRRSV
(Lopez and Osorio, 2004). In addition to the anti-GP3 responses,
other mechanisms of protective immunity against PRRSV also
exist. However, in this study we speciﬁcally addressed the
potential to utilize anti-GP3 responses for cross-protection, and
other mechanisms such as anti-GP5 or anti-GP4 responses may
also be important but are not the scope of present study. Since
other PRRSV structural proteins such as GP4 and GP5 have also
been shown to induce neutralizing antibodies, it will be advanta-
geous in the future to shufﬂe additional structural genes of PRRSV
and incorporate the shufﬂed multiple structural genes into the
backbone virus for enhanced cross-neutralizing ability.Materials and methods
Cells, viruses, and viral genes
The MARC-145 and BHK-21 cells used for virus rescue and
propagation were cultured as described previously (Ni et al.,
2011). The North American type 2 PRRSV was classiﬁed into
9 distinct genetic lineages based on the ORF5 gene sequences of
8,624 PRRSV strains (Shi et al., 2010). In order to generate a
shufﬂed chimeric virus with heterologous cross-neutralizing cap-
ability, we selected six representative strains of PRRSV each from
a genetically distinct lineage or sublineage for the traditional DNA
shufﬂing: MN184B (Accession no. DQ176020, lineage 1), VR2385
(Accession no. JX044140, lineage 5.1), VR2430 (Accession no.
JX050225, lineage 5.2), Chinese highly pathogenic strain JXA1
(Accession no. EF112445, lineage 8.7), FL-12 (Accession no.
AY545985 lineage 8.9), and NADC20 (Accession no. JX069953,
lineage 9). A phylogenetic analysis of the GP3 gene sequences of
the selected strains conﬁrmed that they are genetically distinct
and separated into different lineages or sublineages (Fig. 1A).
Among the six representative PRRSV strains, the GP3 genes of
VR2385 and FL-12 were ampliﬁed from the infectious cDNA
clones pIR-VR2385-CA (Ni et al., 2011) and pFL-12 (generously
provided by Dr. Fernando Osorio and Dr. Asit Pattnaik of the
University of Nebraska-Lincoln, respectively) (Truong et al., 2004).
The GP3 gene of VR2430 was ampliﬁed from the cDNA of a virus
stock. The remaining three GP3 genes (MN184B, JXA1 andNADC20) were commercially (Genscript Inc) synthesized based
on the available sequences.
Traditional DNA shufﬂing of the GP3 genes from six genetically
distinct PRRSV strains
The DNA fragments of the GP3 genes from the six different
strains of PRRSV (Fig. 1A) were equimolarly mixed with 1mg DNA
from each virus, and diluted to a 50 ml reaction in 50 mM
Tris HCl, pH 7.4 and 10 mM MgCl2. The mixture was incubated
at 15 1C for 2 min with 0.15 U of DNase I (Sigma). The digestion
reaction was stopped by adding 5 ml of 0.5M EDTA followed by
15 min incubation at 85 1C for complete inactivation. DNA frag-
ments with the approximate sizes of 50–150 bp were puriﬁed
from 2% agarose gels using Qiaquick gel extraction kit (Qiagen).
The puriﬁed DNA fragments were subsequently added to the Pfu
PCR mixture consisting of 1X Pfu buffer, 0.4 mM each dNTP,
0.06 U Pfu polymerase (Stratagene). A PCR program (95 1C for
4 min; 35 cycles of 95 1C for 30 s, 60 1C for 30 s, 57 1C for 30s,
54 1C for 30s, 51 1C for 30 s, 48 1C for 30s, 45 1C for 30 s, 42 1C for
30 s, 72 1C for 2 min; and ﬁnal incubation at 72 1C for 7 min)
without primers was performed to reassemble the digested DNA
fragments. A 10 ml of the reaction products was loading on the
agarose gel to evaluate the efﬁciency of the reassembly. Primers
g3fu50F and g3fu30R (Table 1) were subsequently used to amplify
by PCR the shufﬂed products excluding the signal peptide
sequence of ORF3, the transcription regular sequence (TRS) and
the overlapping region of the ORF4. The PCR mixture contained
5 ml of reassembled products, 0.2 mM of each primer, 41 ml of
PfuUltra II Hotstart PCR Master Mix (Stratagene). The PCR para-
meters included 4 min at 95 1C; 25 cycles of 30 s at 95 1C, 30 s at
55 1C, 30 s at 72 1C; a ﬁnal 7 min at 72 1C. After ampliﬁcation, a
single band of the shufﬂed products with an expected size was
obtained.
Synthetic DNA shufﬂing of the GP3 genes
Synthetic DNA shufﬂing was performed by assembling degen-
erate oligonucleotides using PCR to recombine the nucleotide
diversity represented in the nt position 151–515 of the GP3 gene
region, excluding the sequences of the signal peptide, TRS and
GP3–GP4 overlap region (Fig. 4). A total of 191 GP3 gene
sequences (including all available full-length GP3 gene sequences
published before April 26th, 2011) from the type 2 PRRSV strains
were retrieved from GenBank database and aligned by the
clustalW method. Subsequently, a total of 9 backbone oligonu-
cleotides representing the most diversity presented by nucleotide
degeneracies were designed on the basis of the consensus
sequence from the multiple sequence alignment. Four of the
9 oligonucleotides were oriented in the forward direction
(g3F1–g3F4), and the remaining 5 were in the reverse direction
(g3R1–g3R5) (Fig. 4). To further increase the assembling efﬁ-
ciency, the overlap regions between different backbone oligonu-
cleotides were designed with conserved sequence with the
backbone parental virus VR2385, and the sequence diversity in
the overlap regions were subsequently introduced by spiking
primers (S1–S12) (Table 1).
The oligonucleotides were commercially synthesized (Invitro-
gen) and assembled under the following conditions. In a 50 ml PCR
reaction system, GoTaqs Green master mix (Promega) was used,
according to the manufacturer’s instruction, with the backbone
oligonucleotides (g3F2–g3F4, g3R2–g3R5) and all spiking primers
with 100 nM each. The oligonucleotides were assembled by a
touch-down PCR with the following parameters: 95 1C for 4 min;
15 cycles of 95 1C for 30 s, 60 1C to 46 1C touch-down (reduce 1 1C
for each cycle) for 45 s, 72 1C for 45 s; 15 cycles of 95 1C for 30 s,
Table 1
Oligonucleotide primers used in this study.
Primers F/Ra Sequence (50–30) Purpose
g3fu50F F CTTTCGAACTCACGGTGAAC Shufﬂed region
g3fu30R R GAAACCAATTGCCGCCGTCGACC Shufﬂed region
EcoRVF F GGAGTTCTTGGTGTCCATTGTTG Flank fragment
g3fu50R R CCGTGTAGTTCACCGTGAGTTCG Flank fragment
g3fu30F F GGTCGACGGCGGCAATTGGTTTCAC Flank fragment
ORF4R R GCCCACCTCATGGTCTCGGGCGTC Flank fragment
g3F1 F GCAATTTTTCTTTCGAACTCACGGTGAAC Backbone oligonucleotide
g3F2 F GCCTCACCCGGCAAGCAGCCRCWSAGVBCYWYGAACCHRGYRVGTCTCTTTGGTGCAGGATAGG Backbone oligonucleotide
g3F3 F TGGTGCCGTCTGGCCTCTCCAGCGAAGGCCACTTGACYAGTGTTTAYGCCTGGTTGGCGTTCCTGTCCTTCAGCTACAC Backbone oligonucleotide
g3F4 F AGTTTATGTTGACATCAAGCAYCAANTYATYTGYGCHGHHCAYGAYGGGVANAACVCCACCTTGCCTCGCCATGACAA Backbone oligonucleotide
g3R1 R GTGAAACCAATTGCCGCCGTCGACC Backbone oligo
g3R2 R GTGAAACCAATTGCCGCCGTCGACCTGRTGYTGGTARTARGTCTGRAAYACGGCTGARAHRTTGTCATGGCGAGGCAAGGT Backbone oligonucleotide
g3R3 R GCTTGATGTCAACATAAACTYBRCTCACATTCCCTATYCCRAATATCTCGGGRTGRAACTGGGCHGTGTAGCTGAAGGACAGGAA Backbone oligonucleotide
g3R4 R GGAGAGGCCAGACGGCACCANRAAHCCYAGHTCGTCRTGRTCDTYCTCNNHVCANCGVTCDTDYCCTATCCTGCACCAAAGAGA Backbone oligonucleotide
g3R5 R GGCTGCTTGCCGGGTGAGGCARRGHGGRCAYACCGTGTAGTTCACCGTGAGTTCGAAAG Backbone oligonucleotide
S1 F TGCCTCACCCGGCARGCDGCC Spike primer
S2 F TGCCTAACCCGGCARGCDGCC Spike primer
S3 F TGCCCAACCCGGCARGCDGCC Spike primer
S4 F TGCCCTACCCGGCARGCDGCC Spike primer
S5 F GTCTYTTTGGTGCAGGATHGG Spike primer
S6 F TGRTNCCGYCTGGCCTYTCCAGCG Spike primer
S7 R GTGTARCTGAAGGACAGAAACGCC Spike primer
S8 R GTGTARCTGAAGGACAAAAACGCC Spike primer
S9 R GTGTARCTGAAGGACAAGAACGCC Spike primer
S10 R GTGTARCTGAAGGACAGGAACGCC Spike primer
S11 R GHTTGATGTCVACATAAACT Spike primer
S12 R TTGTCATGRCGAGRCAAGGTGG Spike primer
a Primer orientations: F; Forward; R; Reverse.
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forward and reverse primers (g3F1 and g3R1) were added to the
reaction and the additional PCR step included 20 cycles of 95 1C
for 30 s, 56 1C for 45 s, 72 1C for 45 s; and a ﬁnal incubation at
72 1C for 7 min. After ampliﬁcation, a single band of the shufﬂed
products with an expected size was visualized and puriﬁed from
2% agarose gels.
Construction of chimeric PRRSV libraries
The DNA-launched PRRSV VR2385 infectious clone pIR-
VR2385-CA (Ni et al., 2011) was used as the genomic backbone
to clone the shufﬂed GP3 gene fragments for chimeric virus
rescue. In order to use the unique restriction sites to insert the
shufﬂed GP3 gene fragment into the full-length pIR-VR2385-CA
infectious clone backbone plasmid, two ﬂanking fragments were
ampliﬁed separately by using two pairs of primers (Table 1),
EcoRVFþg3fu50R and g3fu30FþORF4R, using pIR-VR2385-CA as
the template. Both ﬂanking fragments were then fused to the
shufﬂed GP3 region by a fusion PCR. The fusion products contain-
ing the shufﬂed GP3 gene were subsequently cloned into the
genomic backbone of the pIR-VR2385-CA infectious clone to
construct the chimeric PRRSV libraries. The recombination efﬁ-
ciency of the traditional DNA shufﬂing was analyzed by sequen-
cing the shufﬂed GP3 region from 36 randomly selected clones.
Mutations compared to the parental strains serve as the markers
to delineate regions of crossover. If the sequence is unique for a
particular parental strain between the crossover sites, then that
region between the two crossovers is derived from that particular
parental strain. In the case of traditional DNA shufﬂing, the clones
contained sequences representing all six parental virus strains are
considered as the well-shufﬂed products.
In vitro transfection and immunoﬂuorescence assay (IFA)
To rescue the chimeric viruses, four well-shufﬂed chimeric
clones from the traditional DNA shufﬂing and the library ofrecombinant clones from the synthetic DNA shufﬂing were
transfected into the BHK-21 cells, respectively, as described
previously (Ni et al., 2011). At 24 h post-transfection, the super-
natant of the transfected cells was harvested and subsequently
passaged onto MARC-145 cells. At 24 h post-infection, cells were
ﬁxed with 80% acetone (Sigma) and incubated with anti-PRRSV N
monoclonal antibody SDOW17 (Rural Technologies, Inc) (Fang
et al., 2006; Meng et al., 1996a; Meulenberg et al., 1998) at 37 1C
for 1 h. After washing three times with phosphate buffered saline
(PBS), the cells were then incubated with ﬂuorescein isothiocya-
nate (FITC)-conjugated goat anti-mouse IgG (KPL, Inc) at 37 1C for
45 min. After washing three times with PBS, the stained cells
were visualized with a Nikon Eclipse TE300 ﬂuorescence micro-
scope ﬁtted with a camera (Nikon).
Plaque puriﬁcation
Plaque puriﬁcation was used to select individual clone of
viable chimeric virus from the synthetic DNA shufﬂing library.
Brieﬂy, conﬂuent monolayers of MARC-145 cells cultured in a 6-
well plate were infected with the supernatant of the 1st passage
chimeric virus mixtures that were rescued from the synthetic
shufﬂed library. After 1 h incubation, the inoculum was removed
and the cells were wash three times with PBS, an agar overlay was
applied to the monolayer. Plaques were stained with neutral red
solution (Sigma) at the 3rd DPI at 37 1C. At the 4th day post-
infection, individual plaques were selected and then used to infect
new MARC-145 cells. The GP3 regions of the plaque-puriﬁed
synthetic shufﬂed individual chimeric viruses were ampliﬁed
and sequenced. Four well-shufﬂed chimeric viruses were
selected, and two additional rounds of plaque puriﬁcation were
performed to ensure these viruses were derived from homoge-
nous individual clone.
The GP3 nucleotide sequences of the eight chimeric viruses
and the six parental strains were aligned by clustalWmethod. The
nucleotide bases different from the sequence of the backbone
parental virus VR2385 were indicated (Fig. 2).
L. Zhou et al. / Virology 434 (2012) 96–109 107Growth characterization in vitro
To analyze the growth characteristics of the shufﬂed chimeric
viruses in vitro, conﬂuent monolayers of MARC-145 cells seeded
in 96-well plates were infected with the parental virus VR2385
and chimeric viruses containing the shufﬂed GP3 genes at the
same multiplicity of infection (m.o.i.) of 0.1, respectively. The
infected cells were harvested at 6, 12, 24, 36, 48, 60, 72 and 84 h
post-infection (hpi). The infectious titers of the viruses harvested
at different time points were determined by IFA in MARC-145
cells and quantiﬁed as 50% tissue culture infective dose per ml
(TCID50/ml). Three independent experiments were performed in
this study.
Experimental design for the animal study to characterize the chimeric
viruses
To characterize the infection dynamics of the chimeric viruses
and their ability to induce neutralizing antibodies in pigs, a total
of 30 speciﬁc-pathogen-free (SPF) pigs at 4 weeks of age that were
negative for PRRSV were divided into 10 groups of 3 pigs each.
Pigs in each group were intramuscularly inoculated with 2 ml of
each of the 8 different chimeric viruses (groups 1–8, 2105
TCID50/pig), 2 ml of the parental VR2385 virus (positive control
group, 2105 TCID50/pig) or 2 ml cell culture media (negative
control group). Serum samples from each pig were collected prior
to inoculation and weekly thereafter, and all pigs were eutha-
nized at 42 days post-inoculation (DPI).
Detection of viremia and antibody responses in pigs infected with
chimeric viruses
The infectious virus titers of the chimeric viruses in serum
samples of infected pigs were determined by IFA in MARC-145
cells. Brieﬂy, conﬂuent monolayers of MARC-145 cells cultured in
96-well plates were incubated with 10-fold-serially-diluted
serum samples (100, 101 to 106; 50 ml/well) at 37 1C for 1 h.
The inocula were removed and the cells were washed twice with
PBS, and fresh DMEM media supplemented with 2% fetal bovine
serum was then added to each well. After incubation for 20 h at
37 1C, the cells were ﬁxed with 80% acetone (Sigma) and stained
with anti-PRRSV antibody SDOW17 (Fang et al., 2006; Meng et al.,
1996a; Meulenberg et al., 1998) and FITC-conjugated goat anti-
mouse IgG (KPL, Inc.). The viral titers in serum samples collected
at 7 and 14 DPI were quantiﬁed as TCID50/ml. In addition, the GP3
genes of chimeric viruses recovered from pigs at 14 DPI were
ampliﬁed by RT-PCR using primers EcoRVFþg3fu30R (Table 1)
with the following parameters: 95 1C for 4 min; 40 cycles of 95 1C
for 30s, 51 1C for 60 s, 72 1C for 90 s; and a ﬁnal incubation at
72 1C for 7 min. The PCR products were puriﬁed and sequenced.
The IDEXX HerdCheck X3s ELISA for PRRS was used to detect the
anti-PRRSV antibody response in sera (Iowa State University
Diagnostic Laboratories, Ames, Iowa).
Serum virus neutralization (SVN) assay
Serum samples collected at 42 DPI were used to determine the
presence of neutralizing antibodies and cross-neutralizing ability
of each chimeric virus to the ﬁve homologous/heterologous
parental strains (VR2385, VR2430, MN184B, FL-12 and NADC20),
respectively. Brieﬂy, serum samples were serially diluted 2-fold in
DMEM media supplemented with 2% fetal bovine serum (FBS).
The diluted serum samples, starting at 1:2 dilution, were mixed
with an equal volume of the respective parental virus at a titer of
2103 TCID50/ml and incubated for 1 h at 37 1C. The mixtures
were then added to a 96-well cell culture plate with conﬂuentMARC-145 cells and incubated for 1 h at 37 1C. The inocula were
removed and the cells were washed twice with PBS, and subse-
quently 50 ml of fresh DMEM media supplemented with 2% FBS
was added to each well. After incubation for 20 h at 37 1C, the
cells were ﬁxed with 80% acetone (Sigma) and stained with an
anti-PRRSV antibody SDOW17 (Fang et al., 2006; Meng et al.,
1996a; Meulenberg et al., 1998) by IFA to detect evidence of virus
replication essentially as described above. The neutralizing anti-
body titers were expressed as the highest dilution that showed a
90% or greater reduction in the numbers of ﬂuorescent foci
compared to that of the serum samples from the negative control
group in the same dilution as described previously (Wu et al.,
2001). Each serum sample was independently tested three times,
and the average NA titers of each shufﬂed virus group (average of
three pigs) were calculated and compared with that of backbone
parental VR2385 group by unpaired t test, with 95% conﬁdence
level.
To further investigate the kinetics of neutralizing antibodies,
the neutralizing antibody titers in serum samples collected at 28,
35 and 42 DPI from pigs infected with GP3TS20, GP3TS22 and
VR2385 viruses were also determined.
GP3 epitope analyses
The GP3 amino acid sequences of the chimeric viruses and the
six parental strains were aligned by clustalW method. The
locations of known epitopes in the shufﬂed GP3 region were
annotated in the sequence of the backbone parental virus VR2385,
which was set as the reference. The amino acid sequences of the
six reported epitopes in GP3 gene of PRRSV (Vanhee et al., 2011)
were compared among the chimeric viruses and the six parental
strains.
Statistical analyses
A Student’s t test (unpaired) was used to evaluate the differ-
ences (Po0.05) between the samples from the chimeric virus
groups and samples from VR2385 positive control group.Acknowledgment
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